Telemetry Investments, L.L.C. Meridian Bioscience Inc Transaction History
Telemetry Investments, L.L.C.
- $63.3 Million
- Q4 2022
A detailed history of Telemetry Investments, L.L.C. transactions in Meridian Bioscience Inc stock. As of the latest transaction made, Telemetry Investments, L.L.C. holds 20,285 shares of VIVO stock, worth $0. This represents 1.06% of its overall portfolio holdings.
Number of Shares
20,285
Previous 18,700
8.48%
Holding current value
$0
Previous $590,000
14.24%
% of portfolio
1.06%
Previous 0.76%
Shares
2 transactions
Others Institutions Holding VIVO
# of Institutions
10Shares Held
113KCall Options Held
0Put Options Held
0-
Havens Advisors LLC New York, NY26.8KShares$02.29% of portfolio
-
Advisor Partners LLC Walnut Creek, CA19.7KShares$00.04% of portfolio
-
Sarissa Consulting LLC Santa Monica, CA18.3KShares$00.59% of portfolio
-
Brinker Capital Investments, LLC16KShares$00.01% of portfolio
-
Hightower 6 M Holding, LLC11.8KShares$00.03% of portfolio
About MERIDIAN BIOSCIENCE INC
- Ticker VIVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 43,748,000
- Description
- Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...